Correlation Between ABL Bio and MedPacto

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ABL Bio and MedPacto at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABL Bio and MedPacto into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABL Bio and MedPacto, you can compare the effects of market volatilities on ABL Bio and MedPacto and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABL Bio with a short position of MedPacto. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABL Bio and MedPacto.

Diversification Opportunities for ABL Bio and MedPacto

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between ABL and MedPacto is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding ABL Bio and MedPacto in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MedPacto and ABL Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABL Bio are associated (or correlated) with MedPacto. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MedPacto has no effect on the direction of ABL Bio i.e., ABL Bio and MedPacto go up and down completely randomly.

Pair Corralation between ABL Bio and MedPacto

Assuming the 90 days trading horizon ABL Bio is expected to generate 1.34 times more return on investment than MedPacto. However, ABL Bio is 1.34 times more volatile than MedPacto. It trades about 0.08 of its potential returns per unit of risk. MedPacto is currently generating about -0.14 per unit of risk. If you would invest  2,190,000  in ABL Bio on September 12, 2024 and sell it today you would earn a total of  770,000  from holding ABL Bio or generate 35.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

ABL Bio  vs.  MedPacto

 Performance 
       Timeline  
ABL Bio 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in ABL Bio are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, ABL Bio may actually be approaching a critical reversion point that can send shares even higher in January 2025.
MedPacto 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MedPacto has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

ABL Bio and MedPacto Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ABL Bio and MedPacto

The main advantage of trading using opposite ABL Bio and MedPacto positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABL Bio position performs unexpectedly, MedPacto can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MedPacto will offset losses from the drop in MedPacto's long position.
The idea behind ABL Bio and MedPacto pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets